{"id":"W4402827770","doi":"10.1038/s41375-024-02420-6","title":"Pola-R-CHP or R-CHOEP for first-line therapy of younger patients with high-risk diffuse large B-cell lymphoma: a retrospective comparison of two randomized phase 3 trials","year":2024,"lang":"en","type":"article","venue":"Leukemia","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":true,"ca_institutions":"Roche (Canada)","funders":"Genentech; Swedish Orphan Biovitrum; F. Hoffmann-La Roche; Incyte; BeiGene; Gilead Sciences; MorphoSys; Celgene; Eli Lilly and Company; AstraZeneca; Agios Pharmaceuticals; Roche; Amgen","keywords":"Lymphoma; Medicine; Retrospective cohort study; Oncology; Internal medicine; Randomized controlled trial; Pediatrics","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.01242039,0.0006592872,0.002330711,0.0006735675,0.0003177919,0.001221153,0.0005272736,0.001014933,0.002223534],"category_scores_gemma":[0.01186113,0.0004780402,0.002576052,0.001110312,0.0006665495,0.001038827,0.000465116,0.001107837,0.000266669],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.000769157,"about_ca_system_score_gemma":0.001162914,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0002063271,"about_ca_topic_score_gemma":0.0004373826,"domain_scores_codex":[0.9896166,0.007159593,0.00128014,0.0009346764,0.0007241825,0.0002847638],"domain_scores_gemma":[0.9882279,0.005034811,0.004526763,0.001117539,0.0005032471,0.0005897087],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","study_design_scores_codex":[0.8774405,0.002102919,0.02888604,0.004528878,0.01721407,0.0001683907,0.0001656407,0.0004938575,0.003796794,0.0005457841,0.0006155958,0.0640415],"study_design_scores_gemma":[0.6446019,0.1968007,0.1110913,0.001368865,0.03158814,0.0008510119,0.0002093395,0.001317304,0.001806487,0.001275505,0.008990591,0.00009879356],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9166113,0.06579361,0.004151059,0.0003646691,0.0003506101,0.009030395,0.001534988,0.00005456214,0.002108893],"genre_scores_gemma":[0.9763867,0.008808963,0.003896571,0.0007528675,0.000351787,0.007813502,0.001617599,0.00002089465,0.0003511499],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.01242039,"threshold_uncertainty_score":0.06568605,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.02574011826774529,"score_gpt":0.3359160215656327,"score_spread":0.3101759032978874,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}